<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in patients with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Copeptin and IGFBP-1 were analyzed in 393 patients participating in the <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> Insulin-<z:chebi fb="105" ids="17234">Glucose</z:chebi> Infusion in <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> (DIGAMI) 2 trial </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Copeptin was associated with IGFBP-1 (Spearman rank correlation test, r = 0.53; P &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>During follow-up there were 138 cardiovascular events (cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, and <z:hpo ids='HP_0001297'>stroke</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>In univariate Cox proportional hazard regression analyses both biomarkers were predictors of events: the hazard ratio for log copeptin was 1.59 (95% CI 1.41-1.81; P &lt; 0.001) and for log IGFBP-1 was 1.49 (1.26-1.77; P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>In the final model, adjusting for age and renal function, copeptin was the only independent predictor (1.35 [1.16-1.57]; P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Copeptin is an independent predictor of cardiovascular events and appears to at least partly explain the prognostic impact of IGFBP-1 in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Copeptin may be a pathogenic factor to address to improve outcome in these patients </plain></SENT>
</text></document>